Thermal distribution, physiological effects and toxicities of extracorporeally induced whole‐body hyperthermia in a pig model

by Gerben Lassche, Tim Frenzel, Marcel H. Mignot, Marianne A. Jonker, Johannes G. van derHoeven, Carla M. L. vanHerpen, Gert Jan Scheffer
Published 2020-02-01

Psychological aspects in patients with advanced cancer receiving lifelong systemic treatment: protocol for a scoping review

by Linda Kwakkenbos, Winette T A van der Graaf, Evie E M Kolsteren, Esther Deuning-Smit, Judith B Prins, Carla M L van Herpen, Sophie Lebel, Belinda Thewes, José A E Custers
Published 2021-01-01

Experiences of bereaved family caregivers with shared decision making in palliative cancer treatment: a qualitative interview study

by Sanne P. C. van Oosterhout, Daisy J. M. Ermers, Floor K. Ploos van Amstel, Carla M. L. van Herpen, Yvonne Schoon, Marieke Perry, Maartje van Geel, Evelien J. M. Kuip, Yvonne Engels
Published 2021-09-01

Differences in health care experiences between rare cancer and common cancer patients: results from a national cross-sectional survey

by Eline de Heus, Vivian Engelen, Irene Dingemans, Carol Richel, Marga Schrieks, Jan Maarten van der Zwan, Marc G. Besselink, Mark I. van Berge Henegouwen, Carla M. L. van Herpen, Saskia F. A. Duijts
Published 2021-06-01

Cisplatin inhibits frequency and suppressive activity of monocytic myeloid-derived suppressor cells in cancer patients

by Glenn F. Van Wigcheren, Nienke De Haas, Tom A. Mulder, Sophie K. Horrevorts, Martine Bloemendal, Simone Hins-Debree, Yumeng Mao, Rolf Kiessling, Carla M.L. van Herpen, Georgina Flórez-Grau, Stanleyson V. Hato, I. Jolanda M. De Vries
Published 2021-01-01

Merkel Cell Carcinoma: New Trends

by Ellen M. Zwijnenburg, Satish F.K. Lubeek, Johanna E.M. Werner, Avital L. Amir, Willem L.J. Weijs, Robert P. Takes, Sjoert A.H. Pegge, Carla M.L. van Herpen, Gosse J. Adema, Johannes H. A. M. Kaanders
Published 2021-03-01

Predictive and Prognostic Biomarker Identification in a Large Cohort of Androgen Receptor-Positive Salivary Duct Carcinoma Patients Scheduled for Combined Androgen Blockade

by Gerben Lassche, Yuichiro Tada, Carla M. L. van Herpen, Marianne A. Jonker, Toshitaka Nagao, Takashi Saotome, Hideaki Hirai, Natsuki Saigusa, Hideaki Takahashi, Hiroya Ojiri, Adriana C. H. van Engen-Van Grunsven, Jack A. Schalken, Chihiro Fushimi, Gerald W. Verhaegh
Published 2021-07-01

RAS and BRAF mutations in cell‐free DNA are predictive for outcome of cetuximab monotherapy in patients with tissue‐tested RAS wild‐type advanced colorectal cancer

by Erik J. vanHelden, Lindsay Angus, C. Willemien Menke‐van der Houven van Oordt, Daniëlle A. M. Heideman, Eline Boon, Suzanne C. vanEs, Sandra A. Radema, Carla M. L. vanHerpen, Derk Jan A. deGroot, Elisabeth G. E. deVries, Maurice P. H. M. Jansen, Stefan Sleijfer, Henk M. W. Verheul
Published 2019-11-01